Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Esophageal Achalasia | 11 | 2024 | 35 | 2.330 |
Why?
|
| Natural Orifice Endoscopic Surgery | 12 | 2024 | 39 | 2.280 |
Why?
|
| Heller Myotomy | 3 | 2021 | 5 | 1.010 |
Why?
|
| Stomach | 3 | 2010 | 85 | 0.980 |
Why?
|
| Myotomy | 6 | 2024 | 15 | 0.910 |
Why?
|
| Endoscopy, Gastrointestinal | 5 | 2017 | 74 | 0.870 |
Why?
|
| Colonoscopy | 2 | 2016 | 97 | 0.810 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 5 | 2016 | 46 | 0.710 |
Why?
|
| Pyloromyotomy | 1 | 2021 | 6 | 0.710 |
Why?
|
| Health Resources | 1 | 2021 | 92 | 0.670 |
Why?
|
| Sphincterotomy, Endoscopic | 2 | 2016 | 7 | 0.650 |
Why?
|
| Ascites | 1 | 2019 | 21 | 0.630 |
Why?
|
| Gastroscopy | 4 | 2021 | 21 | 0.620 |
Why?
|
| Esophageal Motility Disorders | 3 | 2023 | 13 | 0.620 |
Why?
|
| Esophageal Sphincter, Lower | 7 | 2023 | 22 | 0.610 |
Why?
|
| Inpatients | 1 | 2021 | 302 | 0.570 |
Why?
|
| Adenoma | 2 | 2015 | 68 | 0.570 |
Why?
|
| Patient Compliance | 2 | 2016 | 358 | 0.540 |
Why?
|
| Patient Readmission | 1 | 2021 | 429 | 0.520 |
Why?
|
| Quality Indicators, Health Care | 2 | 2016 | 334 | 0.490 |
Why?
|
| Barrett Esophagus | 1 | 2015 | 30 | 0.490 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 2015 | 5 | 0.480 |
Why?
|
| Ampulla of Vater | 1 | 2015 | 12 | 0.480 |
Why?
|
| Precancerous Conditions | 1 | 2015 | 70 | 0.470 |
Why?
|
| Liver Cirrhosis | 2 | 2014 | 170 | 0.470 |
Why?
|
| Esophageal Neoplasms | 1 | 2015 | 83 | 0.450 |
Why?
|
| Life Style | 1 | 2015 | 311 | 0.430 |
Why?
|
| Catheter Ablation | 1 | 2015 | 153 | 0.410 |
Why?
|
| Surgical Instruments | 2 | 2010 | 43 | 0.410 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 280 | 0.400 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 337 | 0.400 |
Why?
|
| Quality of Health Care | 2 | 2014 | 517 | 0.390 |
Why?
|
| Disease Progression | 2 | 2015 | 1159 | 0.380 |
Why?
|
| Electric Impedance | 4 | 2024 | 36 | 0.370 |
Why?
|
| Manometry | 2 | 2024 | 27 | 0.370 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 178 | 0.370 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 554 | 0.350 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 295 | 0.350 |
Why?
|
| Treatment Outcome | 13 | 2024 | 5591 | 0.350 |
Why?
|
| Middle Aged | 17 | 2024 | 17364 | 0.350 |
Why?
|
| Pancreatic Neoplasms | 1 | 2013 | 339 | 0.340 |
Why?
|
| Pamphlets | 1 | 2010 | 17 | 0.340 |
Why?
|
| Suture Anchors | 1 | 2009 | 5 | 0.330 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2010 | 91 | 0.330 |
Why?
|
| Aged | 14 | 2024 | 14255 | 0.320 |
Why?
|
| Humans | 29 | 2024 | 62681 | 0.290 |
Why?
|
| Brucellosis | 1 | 2007 | 8 | 0.280 |
Why?
|
| Pancreatic Diseases | 1 | 2007 | 39 | 0.280 |
Why?
|
| Pancreatitis, Chronic | 1 | 2007 | 19 | 0.280 |
Why?
|
| Male | 18 | 2024 | 29486 | 0.280 |
Why?
|
| Drainage | 3 | 2016 | 154 | 0.280 |
Why?
|
| Postoperative Hemorrhage | 2 | 2018 | 38 | 0.270 |
Why?
|
| Retrospective Studies | 8 | 2024 | 6536 | 0.260 |
Why?
|
| Female | 20 | 2024 | 32491 | 0.260 |
Why?
|
| Anxiety | 1 | 2010 | 421 | 0.260 |
Why?
|
| Patient Education as Topic | 1 | 2010 | 462 | 0.260 |
Why?
|
| Swine | 4 | 2010 | 368 | 0.250 |
Why?
|
| Gastrostomy | 3 | 2010 | 29 | 0.240 |
Why?
|
| Hemorrhage | 1 | 2007 | 266 | 0.240 |
Why?
|
| Adult | 13 | 2024 | 16626 | 0.240 |
Why?
|
| Tattooing | 1 | 2024 | 4 | 0.230 |
Why?
|
| Endoscopic Mucosal Resection | 1 | 2024 | 4 | 0.230 |
Why?
|
| Postoperative Complications | 5 | 2021 | 1284 | 0.230 |
Why?
|
| Coloring Agents | 1 | 2024 | 54 | 0.220 |
Why?
|
| Esophagoscopy | 3 | 2024 | 24 | 0.210 |
Why?
|
| Esophageal Spasm, Diffuse | 1 | 2022 | 4 | 0.200 |
Why?
|
| Referral and Consultation | 2 | 2016 | 422 | 0.190 |
Why?
|
| Length of Stay | 3 | 2021 | 804 | 0.190 |
Why?
|
| Argon Plasma Coagulation | 1 | 2021 | 3 | 0.180 |
Why?
|
| Gastric Antral Vascular Ectasia | 1 | 2021 | 4 | 0.180 |
Why?
|
| Hospital Charges | 1 | 2021 | 23 | 0.180 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2021 | 78 | 0.170 |
Why?
|
| Pancreatic Pseudocyst | 2 | 2010 | 12 | 0.160 |
Why?
|
| Pressure | 2 | 2010 | 77 | 0.160 |
Why?
|
| Suture Techniques | 2 | 2010 | 98 | 0.160 |
Why?
|
| Intraoperative Complications | 2 | 2018 | 89 | 0.160 |
Why?
|
| Cholecystectomy, Laparoscopic | 2 | 2017 | 50 | 0.160 |
Why?
|
| Stents | 2 | 2016 | 487 | 0.160 |
Why?
|
| Palliative Care | 2 | 2013 | 226 | 0.160 |
Why?
|
| Tertiary Care Centers | 2 | 2017 | 109 | 0.150 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 2540 | 0.150 |
Why?
|
| Massachusetts | 2 | 2016 | 2061 | 0.150 |
Why?
|
| Pancreatitis | 2 | 2016 | 97 | 0.150 |
Why?
|
| Risk Factors | 2 | 2021 | 5302 | 0.150 |
Why?
|
| Diagnosis, Differential | 2 | 2013 | 964 | 0.140 |
Why?
|
| Cholecystectomy | 1 | 2017 | 34 | 0.140 |
Why?
|
| Databases, Factual | 1 | 2021 | 852 | 0.140 |
Why?
|
| Insufflation | 1 | 2016 | 9 | 0.130 |
Why?
|
| Retroperitoneal Space | 1 | 2016 | 22 | 0.130 |
Why?
|
| Peritoneum | 1 | 2016 | 29 | 0.130 |
Why?
|
| Heart Arrest | 2 | 2018 | 166 | 0.130 |
Why?
|
| Emphysema | 1 | 2016 | 39 | 0.130 |
Why?
|
| Bile Duct Neoplasms | 2 | 2014 | 46 | 0.130 |
Why?
|
| Early Diagnosis | 1 | 2016 | 96 | 0.130 |
Why?
|
| Hospital Mortality | 1 | 2021 | 865 | 0.130 |
Why?
|
| Endoscopy | 1 | 2017 | 108 | 0.130 |
Why?
|
| Pneumopericardium | 1 | 2015 | 3 | 0.120 |
Why?
|
| Prospective Studies | 5 | 2018 | 3258 | 0.120 |
Why?
|
| United States | 2 | 2021 | 7719 | 0.120 |
Why?
|
| Risk Assessment | 2 | 2021 | 2039 | 0.120 |
Why?
|
| Neoplasm, Residual | 1 | 2015 | 42 | 0.120 |
Why?
|
| Disease Management | 1 | 2016 | 234 | 0.120 |
Why?
|
| Cohort Studies | 3 | 2020 | 2539 | 0.110 |
Why?
|
| Common Bile Duct | 1 | 2014 | 19 | 0.110 |
Why?
|
| Dilatation, Pathologic | 1 | 2014 | 31 | 0.110 |
Why?
|
| Gastroenterology | 1 | 2014 | 42 | 0.110 |
Why?
|
| Cholangiocarcinoma | 1 | 2014 | 30 | 0.110 |
Why?
|
| Endosonography | 1 | 2013 | 26 | 0.110 |
Why?
|
| Esophagogastric Junction | 2 | 2023 | 19 | 0.110 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2013 | 63 | 0.110 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 5406 | 0.110 |
Why?
|
| Time Factors | 1 | 2021 | 3742 | 0.100 |
Why?
|
| Physician-Patient Relations | 1 | 2016 | 416 | 0.100 |
Why?
|
| Models, Animal | 2 | 2010 | 235 | 0.100 |
Why?
|
| Catheterization | 2 | 2010 | 111 | 0.100 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 2445 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2015 | 864 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 933 | 0.090 |
Why?
|
| Surgical Stapling | 1 | 2010 | 12 | 0.090 |
Why?
|
| Smoking | 1 | 2015 | 864 | 0.090 |
Why?
|
| Meperidine | 1 | 2010 | 4 | 0.090 |
Why?
|
| Sutures | 1 | 2010 | 41 | 0.080 |
Why?
|
| Midazolam | 1 | 2010 | 12 | 0.080 |
Why?
|
| Mass Screening | 1 | 2016 | 689 | 0.080 |
Why?
|
| Anti-Anxiety Agents | 1 | 2010 | 31 | 0.080 |
Why?
|
| Abdominal Wall | 1 | 2010 | 23 | 0.080 |
Why?
|
| Transducers | 1 | 2010 | 26 | 0.080 |
Why?
|
| Narcotics | 1 | 2010 | 58 | 0.080 |
Why?
|
| Single-Blind Method | 1 | 2010 | 144 | 0.080 |
Why?
|
| Equipment Design | 1 | 2010 | 348 | 0.080 |
Why?
|
| Physicians | 1 | 2014 | 464 | 0.080 |
Why?
|
| Surgical Staplers | 1 | 2008 | 6 | 0.080 |
Why?
|
| Cholestasis | 1 | 2009 | 58 | 0.080 |
Why?
|
| Animals | 4 | 2010 | 20581 | 0.080 |
Why?
|
| Survival Rate | 1 | 2010 | 839 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 220 | 0.070 |
Why?
|
| Operative Time | 2 | 2018 | 91 | 0.070 |
Why?
|
| Hospitalization | 1 | 2014 | 1344 | 0.070 |
Why?
|
| Brunner Glands | 1 | 2007 | 2 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2010 | 987 | 0.070 |
Why?
|
| Cysts | 1 | 2007 | 41 | 0.070 |
Why?
|
| Gastric Mucosa | 1 | 2024 | 53 | 0.060 |
Why?
|
| Injections | 1 | 2024 | 81 | 0.060 |
Why?
|
| Intestinal Mucosa | 1 | 2024 | 244 | 0.050 |
Why?
|
| Patient Selection | 2 | 2018 | 482 | 0.050 |
Why?
|
| Ligation | 1 | 2021 | 38 | 0.040 |
Why?
|
| Hematocrit | 1 | 2021 | 33 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2021 | 120 | 0.040 |
Why?
|
| Alloys | 2 | 2010 | 29 | 0.040 |
Why?
|
| Blood Transfusion | 1 | 2021 | 158 | 0.040 |
Why?
|
| Visual Analog Scale | 1 | 2017 | 9 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2018 | 48 | 0.040 |
Why?
|
| Blood Loss, Surgical | 1 | 2017 | 62 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2018 | 198 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2018 | 188 | 0.030 |
Why?
|
| Internationality | 1 | 2017 | 44 | 0.030 |
Why?
|
| Recurrence | 1 | 2018 | 634 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 1541 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2014 | 475 | 0.020 |
Why?
|
| Viscera | 1 | 2010 | 10 | 0.020 |
Why?
|
| Cholelithiasis | 1 | 2010 | 23 | 0.020 |
Why?
|
| Stainless Steel | 1 | 2009 | 15 | 0.020 |
Why?
|
| Terminally Ill | 1 | 2009 | 16 | 0.020 |
Why?
|
| International Cooperation | 1 | 2009 | 88 | 0.020 |
Why?
|
| Prosthesis Failure | 1 | 2009 | 73 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 170 | 0.020 |
Why?
|
| Mouth | 1 | 2008 | 34 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2009 | 223 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2008 | 111 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 416 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2009 | 576 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 486 | 0.020 |
Why?
|
| Intestinal Polyps | 1 | 2007 | 6 | 0.020 |
Why?
|
| Gastritis | 1 | 2007 | 18 | 0.020 |
Why?
|
| Helicobacter Infections | 1 | 2007 | 55 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2010 | 467 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 1724 | 0.010 |
Why?
|
| Quality of Life | 1 | 2009 | 1221 | 0.010 |
Why?
|